Home Chondrocalcinosis related to familial hypomagnesemia with hypercalciuria and nephrocalcinosis
Article
Licensed
Unlicensed Requires Authentication

Chondrocalcinosis related to familial hypomagnesemia with hypercalciuria and nephrocalcinosis

  • Emine Ayça Cimbek EMAIL logo , Yaşar Şen , Sevil Arı Yuca and Harun Peru
Published/Copyright: January 20, 2015

Abstract

Calcium pyrophosphate dehydrate (CPPD) crystal deposition disease (also known as chondrocalcinosis, CC) is a rare metabolic arthropathy mostly seen in elderly patients. Chondrocalcinosis may be associated with metabolic diseases such as hypomagnesemia when it occurs in young people. We report here a case with hypomagnesemia due to familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) who developed CC during clinical follow-up. To our best knowledge this is the first case of a young patient with CPPD associated with FHHNC.


Corresponding author: Dr. Emine Ayça Cimbek, Division of Pediatric Endocrinology, Selçuk University Medical School, Selçuklu, Konya, Turkey, Phone: +90 332 224 39 98, E-mail:

Acknowledgment

We thank Prof. Martin Conrad who performed the genetic analysis.

References

1. Praga M, Vara J, Gonzalez-Parra E, Andres A, Alamo C, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 1995;47:1419–25.10.1038/ki.1995.199Search in Google Scholar

2. Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999;285:103–6.10.1126/science.285.5424.103Search in Google Scholar

3. McCarty DJ. Calcium pyrophosphate dihydrate crystal deposition disease. In: Schumacher HR Jr, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation, 1993:219–22.Search in Google Scholar

4. Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011;70:563–70.10.1136/ard.2010.139105Search in Google Scholar

5. Ryan LM, McCarty DJ. Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition. Ann Rheum Dis 1995;54:939–41.10.1136/ard.54.12.939Search in Google Scholar

6. Jones AC, Chuck AJ, Arie EA, Green DJ, Doherty M. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 1992;22:188–202.10.1016/0049-0172(92)90019-ASearch in Google Scholar

7. Calo L, Punzi L, Semplicini A. Hypomagnesemia and chondrocalcinosis in Bartter’s and Gitelman’s syndrome: review of the pathogenetic mechanisms. Am J Nephrol 2000;20:347–50.10.1159/000013614Search in Google Scholar PubMed

8. Richette P, Ayoub G, Lahalle S, Vicaut E, Badran AM, et al. Hypomagnesemia associated with chondrocalcinosis: a cross-sectional study. Arthritis Rheum 2007;57:1496–501.10.1002/art.23106Search in Google Scholar PubMed

9. Perez-Ruiz F, Testillano M, Gastaca MA, Herrero-Beites AM. “Pseudoseptic” pseudogout associated with hypomagnesemia in liver transplant patients. Transplantation 2001;71:696–8.10.1097/00007890-200103150-00022Search in Google Scholar PubMed

10. Neame RL, Carr AJ, Muir K, Doherty M. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis 2003;62:513–8.10.1136/ard.62.6.513Search in Google Scholar PubMed PubMed Central

11. Thouverey C, Bechkoff G, Pikula S, Buchet R. Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles. Osteoarthritis Cartilage 2009;17:64–72.10.1016/j.joca.2008.05.020Search in Google Scholar PubMed

12. Pascual E, Sivera F, Andrés M. Synovial fluid analysis forbcrystals. Curr Opin Rheumatol 2011;23:161–9.10.1097/BOR.0b013e328343e458Search in Google Scholar PubMed

13. Zhang W, Doherty M, Pascual E, Barskova V, Guerne PA, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis 2011; 70:571–5.10.1136/ard.2010.139360Search in Google Scholar PubMed

Received: 2013-6-18
Accepted: 2014-11-28
Published Online: 2015-1-20
Published in Print: 2015-5-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Obesity
  3. Childhood obesity at the crossroads
  4. Obesogenic environments: environmental approaches to obesity prevention
  5. Childhood obesity and eating behaviour
  6. Hypothalamic obesity in children: pathophysiology to clinical management
  7. The reliability of body mass index in the diagnosis of obesity and metabolic risk in children
  8. Determining abdominal obesity cut-offs and relevant risk factors for anthropometric indices in Turkish children and adolescents
  9. The effect of body mass index on blood pressure varies by race among obese children
  10. Insulin secretion response during oral glucose tolerance test is related to low cardiorespiratory fitness in obese adolescents
  11. Is there a relationship between cardiovascular risk factors and dehydroepiandrosterone sulfate levels in childhood obesity?
  12. The effect of lifestyle change and metformin therapy on serum arylesterase and paraoxonase activity in obese children
  13. Childhood obesity, thyroid function, and insulin resistance – is there a link? A longitudinal study
  14. Associations between IGF-I, IGF-binding proteins and bone turnover markers in prepubertal obese children
  15. Osteocalcin is inversely associated with adiposity and leptin in adolescent boys
  16. Association between cardiovascular risk factors and carotid intima-media thickness in prepubertal Brazilian children
  17. Insulin resistance and cardiometabolic risk factors in obese children and adolescents: a hierarchical approach
  18. The role of apolipoprotein E polymorphism in improving dyslipidemia in obese adolescents following physical exercise and National Cholesterol Education Program Step II intervention
  19. Review article
  20. Is ultrasound useful in the diagnosis of adolescents with polycystic ovary syndrome?
  21. Original articles
  22. IGF-II expression and methylation in small for gestational age infants
  23. Early screening of FTO and MC4R variants in newborns of Greek origin
  24. Pitfalls in hormonal diagnosis of 17-beta hydroxysteroid dehydrogenase III deficiency
  25. The prevalence of vitamin D deficiency among schoolchildren: a cohort study from Xinxiang, China
  26. Management of testosterone therapy in adolescents and young men with hypogonadism: are we following adult clinical practice guidelines?
  27. Vitamin D status and its associations with components of metabolic syndrome in healthy children
  28. Metformin treatment improves weight and dyslipidemia in children with metabolic syndrome
  29. Patient reports
  30. Hypothyroidism caused by the combination of two heterozygous mutations: one in the TSH receptor gene the other in the DUOX2 gene
  31. Ovarian carcinoma in a 14-year-old with classical salt-wasting congenital adrenal hyperplasia and bilateral adrenalectomy
  32. An asymptomatic mother diagnosed with 3-methylcrotonyl-CoA carboxylase deficiency after newborn screening
  33. A new missense mutation in the BCKDHB gene causes the classic form of maple syrup urine disease (MSUD)
  34. Ovotesticular disorder of sex development with unusual karyotype: patient report
  35. First case report of medium-chain acyl-coenzyme A dehydrogenase deficiency in China
  36. Virilizing adrenal oncocytoma in a 9-year-old girl: rare neoplasm with an intriguing postoperative course
  37. Unexpected clinical features in a female patient with proopiomelanocortin (POMC) deficiency
  38. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation
  39. Cross-reactivity of adrenal steroids with aldosterone may prevent the accurate diagnosis of congenital adrenal hyperplasia
  40. Hyperthyroidism hidden by congenital central hypoventilation syndrome
  41. The use of pamidronate for acute vitamin D intoxication, clinical experience with three cases
  42. Chondrocalcinosis related to familial hypomagnesemia with hypercalciuria and nephrocalcinosis
  43. Cushing syndrome related to leukemic infiltration of the central nervous system
  44. Hashimoto’s encephalopathy: a rare pediatric brain disease
  45. Short communication
  46. A novel ABCD1 gene mutation in a Chinese patient with X-linked adrenoleukodystrophy
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0254/html
Scroll to top button